Replies to post #776214 on NorthWest Biotherapeutics Inc (NWBO)

[Investor082]

Agreed. One way to recover some of the losses may be to use the UK approval spike to take an opposite position because we are now well familiar with the modus operandi here and the history of LP, LG, et al.

You can count on the fact that there will be endless dilution in pennies, disappointing revenue from UK (given no reimbursement support and lack of or no hiring on the commercial front), increased cash requirement both to expand commercialization in the UK and run new clinical trials, etc. All of this will result in increasing dilution and additional pressure on share price. New all time lows will be breached going forward even after UK approval as couple of quarters of disappointing revenue kicks in coupled with delays in launching their trials, Flaskworks delays, etc.

You can also count on the fact that no big pharma or credible institutional investors will be supporting this company.

[AllSheWrote]

You are confusing cause and correlation. The reason this company is circling the drain has 99 percent to do with the way it has been managed and the way its flagship trial was conducted, and 1 percent to do with external factors. Management's failures are why the skeptics became skeptics. I have no doubt there are some paid skeptics, too, but they have zero influence on the stock price. The sooner you recognize that for yourself, the better off you will be.

[Steady_T]

Tuition for the education in the stock market is high. If you learn the lessons you will learn a lot about yourself.

Once you learn enough you can make some money.

NWBO is a tough teacher. It remains to be seen if there will be a diploma at the end or summer school.

Like all longs I think there is a real possibility of making some money with NWBO.
What the appropriate exposure to the risk involved is an individual decision based on your evaluation of the risk vs reward calculation.

Good luck.